multiple sclerosis

Novartis Probes Death Tied To New MS Pill
Pharmalot
Mon, 12/12/11 - 12:48 pm
Novartis
MS
multiple sclerosis
Gilenya
Novartis MS Pill Gilenya Rejected by U.K. Health-Cost Agency
Bloomberg
Wed, 11/30/11 - 07:42 pm
Novartis
MS
multiple sclerosis
Gilenya
Genzyme moves potential MS therapy closer to FDA finish line with positive Phase 3 data
Bizjournals.com
Mon, 11/14/11 - 12:02 pm
Genzyme
MS
multiple sclerosis
FDA
Lemtrada
Biogen-Idec's BG-12 Shines At the Top of the Charts in the Treatment of Relapsing-Remitting Multiple Sclerosis
Bradenton Herald, FL
Sun, 11/6/11 - 12:28 pm
Biogen
BG-12
multiple sclerosis
Teva Pharmaceuticals
Copaxone
CONFIRM
Biogen readies its app after BG-12 beats Copaxone in PhIII MS study
Fierce Biotech
Wed, 10/26/11 - 09:11 am
Teva Pharmaceuticals
multiple sclerosis
MS
Copaxone
Biogen
BG-12
Sanofi boasts superior relapse-free rate for Lemtrada in MS study
Fierce Biotech
Mon, 10/24/11 - 12:03 pm
Lemtrada
Sanofi
MS
multiple sclerosis
Genzyme
Abbott, Biogen Idec say multiple sclerosis drug achieved study goal of decreasing relapse
Yahoo/AP
Mon, 10/24/11 - 11:00 am
Abbott Laboratories
Biogen Idec
MS
multiple sclerosis
daclizumab
Alemtuzumab (Lemtrada) Significantly Reduces Relapses in Multiple Sclerosis vs Interferon Beta-1a in a Phase III Study
Yahoo/BusinessWire
Sat, 10/22/11 - 12:30 pm
alemtuzumab
Lemtrada
Sanofi
Genzyme
multiple sclerosis
Biogen, Questcor, Allergan Up On MS News
Investors.com
Fri, 10/21/11 - 12:50 pm
Biogen Idec
Questcor
Allergan
MS
multiple sclerosis
BG-12
Biogen says potential MS drug outperforms placebo
Yahoo/AP
Fri, 10/21/11 - 10:09 am
MS
Biogen Idec
multiple sclerosis
BG-12
Biogen Idec, Elan Say FDA Extends Date to Decide Tysabri Change
Bloomberg
Thu, 10/20/11 - 09:17 am
Biogen Idec
FDA
Elan
Tysabri
MS
multiple sclerosis
New Data On Teva’s Copaxone® And Laquinimod To Be Highlighted At ECTRIMS/ACTRIMS
The Street
Sat, 10/15/11 - 01:06 pm
Teva Pharmaceuticals
Copaxone
laquinimod
multiple sclerosis
Merck KGaA, Ono Pharma Collaborate
Yahoo/Zacks
Sat, 10/15/11 - 11:34 am
Merck KGaA
Ono Pharmaceutical
ONO-4641
multiple sclerosis
Stimuvax
non-small cell lung cancer
Teva's Copaxone reduced brain volume loss in patients, according to study
Drugstore News
Wed, 10/12/11 - 10:51 am
Copaxone
Teva Pharmaceuticals
MS
multiple sclerosis
Sanofi Earns a "Modest" Win With Positive Oral MS PhIII Data
Motley Fool
Thu, 10/6/11 - 12:01 pm
Sanofi
MS
multiple sclerosis
teriflunomide
Biogen MS trial data reveals no safety surprises
Reuters
Wed, 10/5/11 - 10:49 am
Biogen Idec
multiple sclerosis
MS
BG-12
Antares Scores Key Patent Possibly Linked To TEVA's Copaxone
Seeking Alpha
Fri, 09/30/11 - 10:55 am
Antares
patents
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Questcor Pharmaceuticals sees Acthar Gel MS prescriptions poised for 3rd-quarter growth
Yahoo/AP
Wed, 09/28/11 - 12:32 pm
Questcor
Acthar
multiple sclerosis
MS
Questcor falls on slower new Acthar prescriptions
Yahoo/AP
Mon, 09/12/11 - 01:26 pm
Questcor
Acthar
MS
multiple sclerosis
Teva defense of Copaxone starts today
Pharma Times, UK
Wed, 09/7/11 - 11:20 am
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
patents

Pages